Yiming Mu

12.1k citations
326 papers · 5.1k · 3 hit papers · h-index 35

Impact in

    • Diabetes Management and Research
    • Diabetes Treatment and Management
    • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Genetics top 1%
    • Mesenchymal stem cell research
    • Diabetes and associated disorders

Papers in

    • Diabetes Treatment and Management 46
    • Diabetes, Cardiovascular Risks, and Lipoproteins 44
    • Diabetes Management and Research 40
    • Pituitary Gland Disorders and Treatments 29
    • Pancreatic function and diabetes 36
    • Adrenal and Paraganglionic Tumors 26

Yiming Mu

307 papers receiving 5.0k citations

Yiming Mu's Hit Papers

Efficacy and safety of once weekly semaglutide 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial 2024 · 59 citations
590+1+2Years since publication50100150

Peers

Yiming Mu
Comparison fields: 5 of 135
  • Endocrinology, Diabetes and Metabolism 2.2k
  • Genetics 680
  • Surgery 1.6k
  • Nephrology 240
  • Epidemiology 886
Replace Chan Soo Shin with:
Chan Soo Shin South Korea
Carlo Sabbà Italy
Pedro Iglesias Spain
Moon‐Kyu Lee South Korea
Saula Vigili de Kreutzenberg Italy
Bernhard Paulweber Austria
Yangang Wang China
Juan J. Díez Spain
Christoph Meier Switzerland
Antonio Tiengo Italy
Yiming Mu relative to Chan Soo Shin South Korea Chan Soo Shin's profile →
Citations per field
00.5×3.5×
Chan Soo Shin · 1×
Citations per year

Countries citing papers authored by Yiming Mu

Since Specialization
Citations

This map shows the geographic impact of Yiming Mu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiming Mu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiming Mu more than expected).

Fields of papers citing papers by Yiming Mu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yiming Mu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiming Mu. The network helps show where Yiming Mu may publish in the future.

Co-authors

The 25 scholars most cited alongside Yiming Mu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yiming Mu Line = papers co-authored together Yiming Mu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 326 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2018222
2 2012208
3 2013193
4
Prevalence of obesity and associated complications in China: A cross‐sectional, real‐world study in 15.8 million adults
Hit paper breakdown →
2023175
5 2015125
6 2003114
7 2019113
8 201699
9 201794
10 201390
11 201789
12
Once-Weekly Insulin Icodec vs Once-Daily Insulin Degludec in Adults With Insulin-Naive Type 2 Diabetes
Hit paper breakdown →
202384
13 201881
14 202080
15 201474
16 201560
17 201360
18
Efficacy and safety of once weekly semaglutide 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial
Hit paper breakdown →
202459
19 201557
20 202054

About Yiming Mu

Yiming Mu is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Molecular Biology, Epidemiology and Cardiology and Cardiovascular Medicine, having authored 326 papers that have together received 5.1k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (46 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (44 papers), Diabetes Management and Research (40 papers), Metabolism, Diabetes, and Cancer (37 papers), Pancreatic function and diabetes (36 papers), Pituitary Gland Disorders and Treatments (29 papers), Adrenal and Paraganglionic Tumors (26 papers) and Liver Disease Diagnosis and Treatment (25 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (2.2k citations), Genetics (680 citations), Surgery (1.6k citations), Nephrology (240 citations) and Epidemiology (886 citations). Yiming Mu has collaborated with scholars based in China, United States and Philippines. Frequent co-authors include Weidong Han, Yu Cheng, Haojie Hao, Jiejie Liu, Jingtao Dou, Li Zang, Anping Wang, Weijun Gu, Juming Lu and Kang Chen. Their work appears in journals such as Journal of Diabetes, Frontiers in Endocrinology, Diabetes Obesity and Metabolism, Scientific Reports and Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact